Approval · Notice of Compliance 33318 · 2024
CEREZYME: Notice of Compliance 33318
Issued May 28, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33318
- Date
- May 28, 2024
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative - Change in Product Ownership, and Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEREZYME | 02241751 | Marketed |
Medicinal ingredients
- IMIGLUCERASE 400 UNIT per VIAL